US20250277017A1
University of Texas System
Disclosed herein are antibodies that bind to connexin 43 hemichannels to inhibit or block channel opening. Also disclosed herein are methods for treating or preventing eye diseases, eye injuries, glaucoma, macular degeneration, diabetic retinopathy, retina injury, and optical nerve damage and …